CXCR4 and Miyoshi myopathy: Using multicolor flow-cytometry technique, Paiva et al. showed that the residual disease clones after treatment exhibited high expression of integrins, such as integrin α4, α5, and β1, as well as CXCR4, compared to MM cells isolated before the treatment [66,67].